nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylstilbestrol—COMT—conduct disorder	0.943	1	CbGaD
Diethylstilbestrol—COMT—Enzymatic degradation of Dopamine by monoamine oxidase—MAOA—conduct disorder	0.0147	0.256	CbGpPWpGaD
Diethylstilbestrol—COMT—Clearance of dopamine—MAOA—conduct disorder	0.0106	0.185	CbGpPWpGaD
Diethylstilbestrol—COMT—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00484	0.0846	CbGpPWpGaD
Diethylstilbestrol—COMT—Dopamine metabolism—MAOA—conduct disorder	0.00328	0.0574	CbGpPWpGaD
Diethylstilbestrol—COMT—Biogenic Amine Synthesis—MAOA—conduct disorder	0.00293	0.0512	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—FSH signaling pathway—CGA—conduct disorder	0.00237	0.0414	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.00202	0.0352	CbGpPWpGaD
Diethylstilbestrol—ESRRG—Gene Expression—POLR3A—conduct disorder	0.000904	0.0158	CbGpPWpGaD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000771	0.0135	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000616	0.0108	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—GABRA2—conduct disorder	0.000591	0.0103	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000463	0.00809	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000454	0.00794	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000432	0.00754	CbGpPWpGaD
Diethylstilbestrol—COMT—Biological oxidations—MAOA—conduct disorder	0.000416	0.00727	CbGpPWpGaD
Diethylstilbestrol—ESR2—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.000408	0.00713	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000378	0.0066	CbGpPWpGaD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000369	0.00644	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000362	0.00632	CbGpPWpGaD
Diethylstilbestrol—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.000334	0.00583	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.000291	0.00508	CbGpPWpGaD
Diethylstilbestrol—ESR1—FOXM1 transcription factor network—EP300—conduct disorder	0.000288	0.00504	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000286	0.00499	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—MAOA—conduct disorder	0.000282	0.00493	CbGpPWpGaD
Diethylstilbestrol—ESR1—FOXA1 transcription factor network—EP300—conduct disorder	0.000278	0.00485	CbGpPWpGaD
Diethylstilbestrol—ESR1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000268	0.00468	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000247	0.00431	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Biological oxidations—COMT—conduct disorder	0.000243	0.00425	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Biological oxidations—MAOA—conduct disorder	0.000241	0.00422	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metapathway biotransformation—COMT—conduct disorder	0.00024	0.00419	CbGpPWpGaD
Diethylstilbestrol—ESR1—ATF-2 transcription factor network—EP300—conduct disorder	0.00022	0.00384	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000207	0.00361	CbGpPWpGaD
Diethylstilbestrol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.000206	0.00359	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000201	0.00351	CbGpPWpGaD
Diethylstilbestrol—ESR2—Gene Expression—POLR3A—conduct disorder	0.0002	0.0035	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0002	0.0035	CbGpPWpGaD
Diethylstilbestrol—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000196	0.00343	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Biological oxidations—COMT—conduct disorder	0.000193	0.00338	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.000192	0.00336	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—EP300—conduct disorder	0.000192	0.00335	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—CGA—conduct disorder	0.000178	0.00311	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—CGA—conduct disorder	0.000175	0.00306	CbGpPWpGaD
Diethylstilbestrol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00017	0.00298	CbGpPWpGaD
Diethylstilbestrol—ESR2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00017	0.00297	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000162	0.00282	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—CGA—conduct disorder	0.000159	0.00277	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Biological oxidations—COMT—conduct disorder	0.000153	0.00267	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000152	0.00265	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.000151	0.00263	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—WASF1—conduct disorder	0.00014	0.00245	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000133	0.00232	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Biological oxidations—COMT—conduct disorder	0.000132	0.00231	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.000131	0.00229	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00013	0.00228	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.000116	0.00202	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000112	0.00196	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000108	0.00188	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000107	0.00187	CbGpPWpGaD
Diethylstilbestrol—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000106	0.00186	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000106	0.00185	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.000104	0.00181	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—POLR3A—conduct disorder	0.000101	0.00176	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—DRD4—conduct disorder	9.81e-05	0.00171	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—CGA—conduct disorder	9.21e-05	0.00161	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.15e-05	0.0016	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	8.73e-05	0.00153	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	8.58e-05	0.0015	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CGA—conduct disorder	8.07e-05	0.00141	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—COMT—conduct disorder	8.04e-05	0.0014	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—MAOA—conduct disorder	7.98e-05	0.00139	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CGA—conduct disorder	7.33e-05	0.00128	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—MAOA—conduct disorder	7.11e-05	0.00124	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Biological oxidations—COMT—conduct disorder	7.09e-05	0.00124	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Biological oxidations—MAOA—conduct disorder	7.04e-05	0.00123	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	7e-05	0.00122	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—CGA—conduct disorder	6.89e-05	0.0012	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—HTR2A—conduct disorder	6.4e-05	0.00112	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CGA—conduct disorder	5.79e-05	0.00101	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—WASF1—conduct disorder	5.52e-05	0.000965	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CGA—conduct disorder	5.01e-05	0.000875	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—EP300—conduct disorder	4.84e-05	0.000846	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	4.54e-05	0.000793	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CGA—conduct disorder	4.36e-05	0.000762	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—COMT—conduct disorder	4.16e-05	0.000726	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—MAOA—conduct disorder	4.13e-05	0.000721	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—EP300—conduct disorder	4.12e-05	0.000719	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CGA—conduct disorder	4.07e-05	0.000712	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	4e-05	0.000699	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—DRD4—conduct disorder	3.86e-05	0.000674	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—COMT—conduct disorder	3.64e-05	0.000636	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—MAOA—conduct disorder	3.62e-05	0.000632	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—EP300—conduct disorder	3.45e-05	0.000602	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—EP300—conduct disorder	3.39e-05	0.000592	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—COMT—conduct disorder	3.31e-05	0.000578	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—MAOA—conduct disorder	3.28e-05	0.000574	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—EP300—conduct disorder	3.07e-05	0.000537	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CGA—conduct disorder	2.69e-05	0.000469	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—COMT—conduct disorder	2.61e-05	0.000457	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—MAOA—conduct disorder	2.6e-05	0.000453	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—HTR2A—conduct disorder	2.52e-05	0.00044	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—COMT—conduct disorder	2.26e-05	0.000395	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—MAOA—conduct disorder	2.24e-05	0.000392	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.18e-05	0.00038	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—COMT—conduct disorder	1.97e-05	0.000344	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—MAOA—conduct disorder	1.95e-05	0.000341	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—COMT—conduct disorder	1.84e-05	0.000321	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—MAOA—conduct disorder	1.83e-05	0.000319	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—EP300—conduct disorder	1.78e-05	0.000311	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.77e-05	0.000309	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—EP300—conduct disorder	1.56e-05	0.000273	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—EP300—conduct disorder	1.42e-05	0.000248	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000233	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—COMT—conduct disorder	1.21e-05	0.000212	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—MAOA—conduct disorder	1.2e-05	0.00021	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—EP300—conduct disorder	1.12e-05	0.000196	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—EP300—conduct disorder	9.69e-06	0.000169	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—EP300—conduct disorder	8.44e-06	0.000147	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—EP300—conduct disorder	7.89e-06	0.000138	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—EP300—conduct disorder	5.2e-06	9.09e-05	CbGpPWpGaD
